K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy
These results highlight the potential of K41-A as a candidate drug for the treatment of NB.
Authors
- Selen Kum Özşengezer (ORCID: https://orcid.org/0000-0002-7068-5979)
- Erdal Bedi̇r (ORCID: https://orcid.org/0000-0003-1262-063X)
- Altun Zekiye S
- Gamze Şanlav (ORCID: https://orcid.org/0000-0003-4256-8326)
- Nur Pınar Olgun (ORCID: https://orcid.org/0000-0002-0073-2143)
- Safiye Aktas
Institutions
- Izmir Institute of Technology (TR)
- Dokuz Eylül University (TR)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-12-27
- DOI
- https://doi.org/10.1093/jpp/rgaf131
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00